Dr. Lauren Gluck, MD

NPI: 1033524780
Total Payments
$53,848
2024 Payments
$22,475
Companies
19
Transactions
236
Medicare Patients
362
Medicare Billing
$61,395

Payment Breakdown by Category

Consulting$39,590 (73.5%)
Food & Beverage$11,278 (20.9%)
Travel$2,734 (5.1%)
Education$245.32 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $39,590 15 73.5%
Food and Beverage $11,278 205 20.9%
Travel and Lodging $2,734 12 5.1%
Education $245.32 4 0.5%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $15,048 24 $0 (2024)
EMD Serono, Inc. $14,524 42 $0 (2024)
TG Therapeutics, Inc. $8,721 22 $0 (2024)
Alexion Pharmaceuticals, Inc. $4,580 18 $0 (2024)
Genentech, Inc. $2,508 4 $0 (2024)
Novartis Pharmaceuticals Corporation $2,222 46 $0 (2024)
E.R. Squibb & Sons, L.L.C. $1,381 2 $0 (2024)
Janssen Pharmaceuticals, Inc $1,154 7 $0 (2022)
GENZYME CORPORATION $984.81 9 $0 (2024)
Biogen, Inc. $860.05 17 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $22,475 76 TG Therapeutics, Inc. ($7,783)
2023 $14,312 68 EMD Serono, Inc. ($10,993)
2022 $13,766 47 Genentech USA, Inc. ($8,018)
2021 $1,947 22 Janssen Pharmaceuticals, Inc ($1,076)
2020 $342.07 9 Alexion Pharmaceuticals, Inc. ($133.05)
2019 $788.13 12 Alexion Pharmaceuticals, Inc. ($493.58)
2018 $218.12 2 Biogen, Inc. ($119.75)

All Payment Transactions

236 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/20/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $17.39 General
Category: Inflammation/Rare Disease
12/16/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Consulting Fee Cash or cash equivalent $500.00 General
Category: Immunology
12/12/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $121.69 General
12/02/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,280.00 General
11/15/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $31.14 General
Category: Neurology
11/14/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $27.73 General
Category: Immunology
11/04/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $97.99 General
10/25/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $43.04 General
10/24/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $121.26 General
Category: Neurology
10/11/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $28.18 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
10/01/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $94.24 General
10/01/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $21.28 General
09/25/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Consulting Fee Cash or cash equivalent $2,700.00 General
Category: Immunology
09/20/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $14.00 General
09/19/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $115.65 General
09/18/2024 Genentech USA, Inc. Ocrevus (Biological) Food and Beverage In-kind items and services $146.25 General
Category: Immunology
09/18/2024 Genentech USA, Inc. Ocrevus (Biological) Food and Beverage In-kind items and services $28.07 General
Category: Immunology
09/17/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $76.47 General
Category: Immunology
09/17/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $57.29 General
Category: Immunology
09/09/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $24.86 General
Category: Neurology
09/07/2024 Genentech USA, Inc. Ocrevus (Biological) Consulting Fee Cash or cash equivalent $5,690.00 General
Category: Immunology
09/07/2024 Genentech USA, Inc. Ocrevus (Biological) Travel and Lodging In-kind items and services $248.85 General
Category: Immunology
09/07/2024 Genentech USA, Inc. Ocrevus (Biological) Travel and Lodging In-kind items and services $228.95 General
Category: Immunology
09/07/2024 Genentech USA, Inc. Ocrevus (Biological) Travel and Lodging Cash or cash equivalent $212.88 General
Category: Immunology
09/07/2024 Genentech USA, Inc. Ocrevus (Biological) Food and Beverage Cash or cash equivalent $110.17 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 124 160 $147,479 $19,623
2022 3 95 120 $115,126 $16,601
2021 5 88 113 $108,011 $16,401
2020 3 55 70 $63,906 $8,770
Total Patients
362
Total Services
463
Medicare Billing
$61,395
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 33 66 $51,920 $7,951 15.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 45 45 $63,414 $7,004 11.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 20 20 $10,100 $1,706 16.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 11 11 $12,955 $1,697 13.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 15 18 $9,090 $1,266 13.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 50 50 $71,993 $9,137 12.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 23 43 $29,366 $5,133 17.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 22 27 $13,767 $2,332 16.9%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 22 42 $27,840 $5,772 20.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 31 32 $46,076 $5,646 12.3%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 11 11 $12,105 $2,049 16.9%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 12 13 $14,475 $1,750 12.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 12 15 $7,515 $1,185 15.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 30 30 $42,696 $5,293 12.4%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 13 22 $13,200 $2,140 16.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 12 18 $8,010 $1,336 16.7%

About Dr. Lauren Gluck, MD

Dr. Lauren Gluck, MD is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1033524780.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lauren Gluck, MD has received a total of $53,848 in payments from pharmaceutical and medical device companies, with $22,475 received in 2024. These payments were reported across 236 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($39,590).

As a Medicare-enrolled provider, Gluck has provided services to 362 Medicare beneficiaries, totaling 463 services with total Medicare billing of $61,395. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Bronx, NY
  • Active Since 06/20/2014
  • Last Updated 08/07/2019
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1033524780

Products in Payments

  • OCREVUS (Biological) $10,338
  • BRIUMVI (Drug) $8,721
  • Ocrevus (Biological) $7,097
  • Mavenclad (Drug) $1,964
  • KESIMPTA (Drug) $1,334
  • ZEPOSIA (Drug) $874.03
  • VUMERITY (Drug) $428.55
  • UPLIZNA (Biological) $240.11
  • TYSABRI (Biological) $234.94
  • UPLIZNA (Drug) $172.98
  • MAVENCLAD (Drug) $172.48
  • SOLIRIS (Biological) $170.52
  • PURIFIED CORTROPHIN GEL (Drug) $153.12
  • SOLIRIS (Drug) $122.03
  • Enspryng (Biological) $121.45
  • BOTOX (Biological) $109.93
  • Rebif (Biological) $100.00
  • LEMTRADA (Drug) $99.00
  • Hizentra (Biological) $98.37
  • UBRELVY (Drug) $92.05

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Bronx